e-learning
resources
Munich 2014
Sunday, 07.09.2014
Pathology and prognostic factors of thoracic tumours
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does smoking status at time of diagnosis of lung cancer independently predict survival at 6 months?
R. Roberts, K. Lewis (Llanelli, Swansea, United Kingdom)
Source:
International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Session:
Pathology and prognostic factors of thoracic tumours
Session type:
Poster Discussion
Number:
504
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Roberts, K. Lewis (Llanelli, Swansea, United Kingdom). Does smoking status at time of diagnosis of lung cancer independently predict survival at 6 months?. Eur Respir J 2014; 44: Suppl. 58, 504
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Does smoking status after a diagnosis of lung cancer matter? Impact of quitting on 1 year survival
Source: International Congress 2015 – Advances in the therapy of lung cancer
Year: 2015
Lung cancer and socioeconomic status: Differences in demographics, stage, treatment and mortality in a lung cancer centre
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Impact of persistence of smoking on recurrence after early stage lung surgery
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
Smoking cessation in patients with cancer under real life conditions
Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products
Year: 2016
Feasibility of smoking cessation services for patients with lung cancer; a patient centred approach
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Does bronchial location of lung cancer influence overall survival?
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Incidence of lung cancer in smokers with and without COPD: Observational study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Description of smoking status in pulmonary patient in the discharge list
Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease
Year: 2013
Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males
Source: Eur Respir J 2005; 25: 618-625
Year: 2005
Is there a difference in the incidence of metastasis at diagnosis of lung cancer between smokers and non smokers?
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
The effect of occupational farming on lung function development in young adults: A 15 year follow-up study
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015
Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Survival in patients with lung cancer, with and without self reported cardiovascular disease the HUNT study
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
Breastfeeding is associated with increased lung function at 18 years of age: a cohort study
Source: Eur Respir J 2012; 39: 985-991
Year: 2012
Metabolomic profiles in lung cancer subjects and healthy controls. Influence of smoking tobacco exposure
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Serum selenium level and risk of lung cancer mortality: a 16-year follow-up of the Copenhagen Male Study
Source: Eur Respir J 2012; 39: 1443-1448
Year: 2012
Characteristics of smoking behaviour in patients post-curative resection of stage 1 lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Lung cancer survival in never smokers. Results from the LCRINS study
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept